Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · July 02, 2023

Efficacy and Safety of Nivolumab for Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma

Journal of the European Academy of Dermatology and Venereology: JEADV

 

Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Nivolumab for locally advanced and metastatic cutaneous squamous cell carcinoma (NIVOSQUACS study)-Phase II data covering impact of concomitant haematological malignancies
J Eur Acad Dermatol Venereol 2023 May 21;[EPub Ahead of Print], R Lang, T Welponer, E Richtig, I Wolf, C Hoeller, C Hafner, VA Nguyen, J Kofler, M Barta, P Koelblinger, W Hitzl, M Emberger, M Laimer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading